<SEC-DOCUMENT>0001193125-23-205064-index.html : 20230807
<SEC-HEADER>0001193125-23-205064.hdr.sgml : 20230807
<ACCEPTANCE-DATETIME>20230807165757
ACCESSION NUMBER:		0001193125-23-205064
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20230807
DATE AS OF CHANGE:		20230807
EFFECTIVENESS DATE:		20230807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Autolus Therapeutics plc
		CENTRAL INDEX KEY:			0001730463
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-273776
		FILM NUMBER:		231148290

	BUSINESS ADDRESS:	
		STREET 1:		THE MEDIAWORKS
		STREET 2:		191 WOOD LANE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W12 7FP
		BUSINESS PHONE:		44 20 3829 6230

	MAIL ADDRESS:	
		STREET 1:		THE MEDIAWORKS
		STREET 2:		191 WOOD LANE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W12 7FP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Autolus Therapeutics Ltd
		DATE OF NAME CHANGE:	20180205
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d391286ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d391286ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d391286dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d391286dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d391286dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d391286dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d391286dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: d391286dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g391286g16e41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g391286g16e41.jpg

</DOCUMENT>
</SEC-DOCUMENT>